Redburn Atlantic Initiates Coverage On Charles River with Sell Rating, Announces Price Target of $151
Portfolio Pulse from Benzinga Newsdesk
Redburn Atlantic has initiated coverage on Charles River Laboratories (NYSE:CRL) with a Sell rating and set a price target of $151.
October 14, 2024 | 4:14 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Redburn Atlantic has initiated coverage on Charles River Laboratories with a Sell rating and a price target of $151, indicating a bearish outlook.
The initiation of coverage with a Sell rating and a price target of $151 suggests a negative outlook on Charles River's stock. This could lead to a decrease in investor confidence and a potential short-term decline in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100